Blood Inflammatory Markers and Cytokines in COVID‐19 Patients With Bacterial Coinfections
2024

Blood Inflammatory Markers and Cytokines in COVID-19 Patients With Bacterial Coinfections

Sample size: 235 publication Evidence: high

Author Information

Author(s): Bi Qingqing, Zhu Jie, Zheng Jinju, Xu Qingyun, Chen Juan, Zhang Lei, Mu Xiaofeng

Primary Institution: Qingdao Central Hospital

Hypothesis

This study investigated whether there were differences in levels of serum inflammatory markers in COVID-19 patients with bacterial coinfections compared with those without bacterial infection.

Conclusion

Serum PCT and CRP levels in COVID-19 patients with bacterial coinfection are higher than those without bacterial infection.

Supporting Evidence

  • Serum levels of CRP and PCT were significantly higher in the bacteria-positive group.
  • Proinflammatory cytokines were elevated in COVID-19 patients with bacterial coinfections.
  • Common bacterial species included Acinetobacter baumannii and Klebsiella pneumoniae.
  • Patients with bacterial coinfections had worse outcomes compared to those without.

Takeaway

This study found that COVID-19 patients with bacterial infections have higher levels of certain blood markers, which can help doctors understand how sick the patients are.

Methodology

The study included 235 COVID-19 inpatients, divided into bacteria-positive and bacteria-negative groups, comparing levels of inflammatory markers and cytokines.

Limitations

Vaccination status was not included, and there was no continuous monitoring of inflammatory markers for individual patients.

Participant Demographics

The sample included 1415 males and 831 females aged between 23 and 98.

Statistical Information

P-Value

p<0.001

Statistical Significance

p<0.001

Digital Object Identifier (DOI)

10.1002/iid3.70105

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication